Life sciences firm ReNeuron said yesterday that clinical trials of its stem cell treatment for stroke patients at Glasgow's Southern General Hospital is running to plan, with no adverse effects reported to date.
http://www.scotsman.com/business/management/business-news-in-brief-reneuron-ga-engineering-ford-1-2765126
http://www.scotsman.com/business/management/business-news-in-brief-reneuron-ga-engineering-ford-1-2765126
No comments:
Post a Comment